Search Immortality Topics:



MediMap – pharmacogenomic testing for adults and children …

Posted: August 27, 2017 at 6:44 am

MediMap is a one-time Pharmacogenomics (or "PGx") test that may indicate how a person will respond to specific prescription medications. Your MediMap test results can help guide your healthcare providers to ensure better medication choices and doses based on your genetic makeup... leading to more effective illness management and improved health. The future of medicine is about putting into practice the knowledge that with prescription medicines and dosage amounts, one size does NOT fit all.

The MediMap test is available for all ages; everyone in the family including newborns can benefit from pharmacogenomics testing.

Please note: some studies may overlap; for example, a MediMap multi-drug panel may include the specific drug(s) you were looking to be tested for within a condition-specific panel. A genetic counselor will go over your best options during your consult.

What is pharmacogenomics?+

Pharmacogenomics is the study of how people's genes affect their response to medications.The term pharmacogenomics (also called PGx) is a combination of pharmacology (the study of medications) and genomics (the study of how peoples genetic information can influence their health).PGx may be used to help choose the best medications and doses for you.

What is MediMap?+

MediMap is a pharmacogenomic test that helps guide you and your healthcare providers to better medication choices and doses for you. Until recently, most medicines have been developed and given to patients in a "one size fits all" approach.However, people respond differently to medications due, in part, to their genetic makeup. While some people will find a medication helpful, others may not respond to that medication at all. Some people will need a dose that is higher or lower than what is usually prescribed. Even others may have negative side effects (called adverse drug reactions).MediMap looks at specific genetic changes (called variants) that influence a persons response to many medications.

Does MediMap cover all prescription medications?+

While the number of personalized medicines increases steadily every year, not all medications can yet be connected with genetic changes that influence a persons response to medications.Also, there are other medications (besides those included in our tests) that have been reported to be affected by pharmacogenomic variants. However, at this time, there is not enough evidence available to include them on our reports. To help you better understand differences between evidence levels, we differentiate between "actionable" and "informative" information on our reports."Actionable" means there are expert recommendations to help guide clinical treatment; and "informative" means there is insufficient evidence, at this time, and clinical use of this information is optional.You can see which prescription medications are covered in each MediMap tests on our MediMap test comparison sheet.

Which MediMap test is best for me?+

At your appointment, you will meet with a genetic counselor to discuss available testing options. Factors to consider may include: medications you are currently taking, those you might be prescribed in the future, and a history of medication side effects or ineffectiveness. Our goal is for you to have a good understanding of how pharmacogenomic testing may help you, and allow you and your physician to make the best decisions for you.

Are my results confidential?+

Yes. The results will be entered into the secure Inova electronic medical record, and a copy of the report will be mailed to your home. You are responsible for sharing your test results with your healthcare providers.

What will happen to my DNA sample?+

Your DNA sample will be kept for at least 90 days after the MediMap report has been sent to you. At that time, the sample will be disposed or de-identified (name and other identifiers are removed) depending on your selection at the time you authorize the test. If your sample is de-identified, it may be used for quality control purposes, to develop new tests, or for educational activities. No clinical tests other than MediMap will be performed using your DNA sample.

Read the original:
MediMap - pharmacogenomic testing for adults and children ...

Recommendation and review posted by Guinevere Smith